-
Remarkable cost advantage of industrial production of retroviral vector: brilliant speech of founderFrom June 27 to 28, 2022, the 4th Biomedicine Future Leaders Summit 2022 was held in Shenzhen, Guangdong, as scheduled. Professor Shi Yuanyuan, the founder of...06-29 -
Significant cost advantage in industrialized production of retroviral vectorsOn June 27-28, 2022, the fourth Biouture 2022 Biomedicine Future Leaders Summit was held in Shenzhen, Guangdong as scheduled. Professor Shi Yuanyuan, founder of...06-27
-
Professor Wang Jianxun, a scientist, delivered an important speech at the 14th China Bioindustry ConFrom June 10 to 12, 2022, the 14th China Bioindustry Conference was successfully held in Guangzhou International Bio Island. As an important platform for the ...06-22 -
Arterial Network exclusive interview with our company: to be a water seller in the industry and builIn January 2022, Arterial Network conducted an exclusive interview with our company. Professor Wang Jianxun, the chief scientist, introduced the core team membe...01-19 -
Zhongshan Municipal Human Resources and Social Security Bureau awarded Guangdong Provincial Doctor WIn December 2021, Zhongshan Human Resources and Social Security Bureau held a licensing ceremony for the five newly established doctoral workstations, and our c...12-30 -
Professor Shi Yuanyuan was invited to visit the Interventional and Cell Therapy Center of Shenzhen HRecently, Professor Shi Yuanyuan, the founder and chairman of Shenzhen Cell Valley Biomedical Co., Ltd., and Dr. Yang Borui, the executive president of Guangdon...06-05
